Analgesia for 2nd Trimester Termination of Pregnancy

• Status: Terminated
• Trial end date: 2014-01-01
• Target enrollment: 0
• Participant gender: Female

Summary

There has been very little investigation into the management of pain from 2nd trimester termination of pregnancy or unexpected fetal loss. The standard of practice in North America is usually intravenous patient controlled analgesia (IV PCA), using a narcotic wuch as fentanyl. The goal of this study is to compare the quality of recovery after termination of pregnancy using fentanyl IV PCA or patient controlled epidural analgesia (PCEA), a standard of care for live births. The study will be conducted as a randomized controlled trial.

• Phase: N/A
• Accepts Healthy Volunteers?: Accepts Healthy Volunteers

Details

• Lead Sponsor: Samuel Lunenfeld Research Institute, Mount Sinai Hospital
• Treatments: Bupivacaine; Citric Acid; Fentanyl; Sodium Citrate

Criteria

Inclusion Criteria:

• interruption of pregnancy between 12 and 23 6/7 weeks

Exclusion Criteria:

• documented allergy to fentanyl or bupivacaine

• coagulopathy

• drug or narcotic abuse

• contraindication to neuraxial analgesia

• inability to comply with IVPCA or PCEA

• inability to complete the QoR-40 questionnaire

• TOP due to maternal problems